Change in Director(s)

July 26, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: LALPATHLAB Scrip Code: 539524 Sub: Intimation – Tenure Completion of an Independent Director Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”) Dear Sir/ Madam, In terms of provisions of Regulation 30 of the Listing Regulations, we would like to inform you that, Mr. Gurinder Singh Kalra (DIN: 10197218) has completed his current tenure as an Independent Director of the Company on July 26, 2026 (closing business hours) and consequently ceases to be an Independent Director of the Company with effect from July 26, 2026 (closing business hours). The details as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-POD-1/P/CIR/2023/123 dated July 13, 2023, is attached herewith as an “Annexure- A”. We request you to please take the same on record. Thanking You, Yours Faithfully, For Dr. Lal PathLabs Limited Vinay Gujral Company Secretary & Compliance Officer Encl.: As above Annexure-A Particulars Mr. Gurinder Singh Kalra (DIN: 10197218) Reasons for change viz appointment/ Cessation due to completion of tenure as reappointment, resignation, removal, death or Independent Director of the Company otherwise Date of appointment/re-appointment/ cessation (as July 26, 2026 (closing business hours) applicable) & term of appointment/re-appointment; Brief Profile (in case of appointment) Disclosure of relationships between Directors (in Not Applicable case of appointment of a director)